Pesce, Francesco
 Distribuzione geografica
Continente #
AS - Asia 1.190
SA - Sud America 602
NA - Nord America 362
EU - Europa 276
AF - Africa 32
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.466
Nazione #
BR - Brasile 483
SG - Singapore 459
US - Stati Uniti d'America 317
CN - Cina 308
VN - Vietnam 231
IT - Italia 114
AR - Argentina 50
ID - Indonesia 38
DE - Germania 29
HK - Hong Kong 27
KR - Corea 27
RU - Federazione Russa 25
BD - Bangladesh 22
EC - Ecuador 22
MX - Messico 21
FR - Francia 20
IN - India 20
CA - Canada 17
FI - Finlandia 16
CO - Colombia 14
GB - Regno Unito 12
ZA - Sudafrica 12
IE - Irlanda 11
PY - Paraguay 11
JP - Giappone 10
NL - Olanda 10
SE - Svezia 10
IQ - Iraq 9
CL - Cile 8
PL - Polonia 8
UZ - Uzbekistan 8
MA - Marocco 7
TR - Turchia 6
VE - Venezuela 6
UY - Uruguay 5
AT - Austria 4
KE - Kenya 4
DO - Repubblica Dominicana 3
GR - Grecia 3
KZ - Kazakistan 3
LT - Lituania 3
NZ - Nuova Zelanda 3
PE - Perù 3
SA - Arabia Saudita 3
AL - Albania 2
CI - Costa d'Avorio 2
DZ - Algeria 2
EG - Egitto 2
ES - Italia 2
JO - Giordania 2
NP - Nepal 2
PH - Filippine 2
TN - Tunisia 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
LB - Libano 1
MM - Myanmar 1
NI - Nicaragua 1
OM - Oman 1
PK - Pakistan 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.466
Città #
Singapore 150
Hefei 105
Ho Chi Minh City 91
Beijing 70
Ashburn 43
Hanoi 41
São Paulo 40
Kent 39
Rome 35
Seoul 27
Hong Kong 26
Dallas 16
Boardman 15
Lappeenranta 14
Rio de Janeiro 14
Haiphong 12
Munich 11
New York 11
Salvador 11
Council Bluffs 10
Los Angeles 10
Tokyo 10
Belo Horizonte 9
Da Nang 9
Dublin 9
Jakarta 9
Moscow 9
Curitiba 8
Guayaquil 7
Roubaix 7
Santa Clara 7
Tashkent 7
Brasília 6
Chennai 6
Chicago 6
Dhaka 6
Guarulhos 6
Manaus 6
Mexico City 6
Nuremberg 6
Porto Alegre 6
Tây Ninh 6
Atlanta 5
Buffalo 5
Falkenstein 5
Montreal 5
Recife 5
Sorocaba 5
Thái Bình 5
Thái Nguyên 5
Bagnoli Irpino 4
Bauru 4
Biên Hòa 4
Bragança Paulista 4
Campinas 4
Can Tho 4
Fairfield 4
Frankfurt am Main 4
Johannesburg 4
Montevideo 4
Nairobi 4
Pelotas 4
Quito 4
Ribeirão Preto 4
Santa Fe 4
Santo André 4
Shanghai 4
Sumaré 4
São José 4
São José do Rio Preto 4
Tianjin 4
Uberlândia 4
Warsaw 4
Ankara 3
Asunción 3
Bogotá 3
Brooklyn 3
Campos dos Goytacazes 3
Caxias do Sul 3
Colombo 3
Curvelo 3
Florianópolis 3
Formosa 3
Frascati 3
Houston 3
Huế 3
Hải Dương 3
Limeira 3
Mumbai 3
Osasco 3
Palhoça 3
Phoenix 3
Quận Chín 3
Ribeirão das Neves 3
Riobamba 3
Rosario 3
Santa Maria 3
Santiago 3
Santiago de Cali 3
São Bernardo do Campo 3
Totale 1.155
Nome #
Potential Add-On Benefits of Dietary Intervention in the Treatment of Autosomal Dominant Polycystic Kidney Disease 80
Clinical and Economic Impact of Early Diagnosis of Chronic Kidney Disease in General Practice: The Endorse Study 77
Immunosuppressive therapy and oral anticoagulation in kidney transplant recipients: Direct oral anticoagulants versus vitamin-k antagonists 72
Gut-Derived Uremic Toxins in CKD: An Improved Approach for the Evaluation of Serum Indoxyl Sulfate in Clinical Practice 66
Updates on C3 Glomerulopathy in Kidney Transplantation: Pathogenesis and Treatment Options 65
Late Recurrence of C3 Glomerulopathy After SARS-CoV-2 Infection in a Long-Term Kidney Transplant Recipient: A Case Report 64
Underlying Genetics of aHUS: Which Connection with Outcome and Treatment Discontinuation? 64
Epitope Spreading in Immune-Mediated Glomerulonephritis: The Expanding Target 63
WWP2 Regulates Renal Fibrosis and the Metabolic Reprogramming of Profibrotic Myofibroblasts 56
Pre-Transplant Expression of CCR-2 in Kidney Transplant Recipients Is Associated With the Development of Delayed Graft Function 56
Urinary epidermal growth factor/monocyte chemotactic peptide 1 ratio as non-invasive predictor of Mayo clinic imaging classes in autosomal dominant polycystic kidney disease 55
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 54
Is there a role in acute kidney injury for FGF23 and Klotho? 51
Assessment and management of heart failure in patients with chronic kidney disease 48
Correlation between cephalic screw positioning of Standard Gamma 3 Nail for intertrochanteric fractures and cut-out incidence 47
Network Proximity-Based Drug Repurposing Strategy for Early and Late Stages of Primary Biliary Cholangitis 45
Clinical Outcomes in the Treatment of Pertrochanteric Femur Fractures: A Retrospective Cohort Study 45
Genome-wide scan identifies a copy number variable region at 3p21.1 that influences the TLR9 expression levels in IgA nephropathy patients 44
Elevated levels of IL-6 in IgA nephropathy patients are induced by an epigenetically driven mechanism modulated by viral and bacterial RNA 44
Potassium management and heart failure: a nephrologist's perspective 44
Real-world data in lupus nephritis: results from a European survey on renal function testing and burden of disease progression 44
Immune abnormalities in IgA nephropathy 44
Mild cognitive impairment and kidney disease: Clinical aspects 43
International Nephrology Masterclass in Chronic Kidney Disease: Rationale, Summary, and Future Perspectives 43
Safety and efficacy of tixagevimab/cilgavimab for pre-exposure prophylaxis in kidney transplant recipients: a multicenter retrospective cohort study 43
Classification of Glomerulonephritis with CNN and Self-Attention Networks in Individual Glomeruli in Nephropathology 42
Recurrent urinary tract infections in kidney transplant recipients during the first-year influence long-term graft function: a single-center retrospective cohort study 42
Feasibility of routine ultrasound-guided percutaneous transluminal angioplasty in the treatment of native arteriovenous fistula dysfunction 41
Pentraxin 3: Potential prognostic role in SARS-CoV-2 patients admitted to the emergency department 41
Identification of glomerulosclerosis using IBM Watson and shallow neural networks 40
SGLT2 inhibitors, beyond glucose-lowering effect: Impact on nephrology clinical practice 40
Helicobacter pylori-induced inflammation masks the underlying presence of low-grade dysplasia on gastric lesions 40
Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy 40
High levels of gut-homing immunoglobulin A+ B lymphocytes support the pathogenic role of intestinal mucosal hyperresponsiveness in immunoglobulin A nephropathy patients 40
Permutation-Invariant Cascaded Attentional Set Operator for Computational Nephropathology 40
Kinetics of humoral immune response and severity of infection after three doses of SARS-CoV-2 mRNA vaccine in a large cohort of kidney transplant recipients 40
Predictive machine learning models and survival analysis for covid-19 prognosis based on hematochemical parameters 40
Ultrasonography for diagnosis and management of nephrolithiasis: state of the art and new perspectives 39
Glomerulonephritis in AKI: From Pathogenesis to Therapeutic Intervention 39
Treatment Optimization and Standard of Care Adherence in CKD Primary Care: the TOSCA-CKD project 39
Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy 39
“The Disease Awareness Innovation Network” for chronic kidney disease identification in general practice 39
The new frontier in endovascular treatment of arteriovenous fistula stenosis: The role of ultrasound-guided percutaneous transluminal angioplasty 38
Quantitative imaging in nephrology: Limits and potentials of elastosonography 36
Contrast-enhanced ultrasound in peritoneal dialysis: when and how to perform it 36
Can vitamin D status influence seroconversion to SARS-COV2 vaccines? 35
GLP-1 receptor agonists in the treatment of diabetes mellitus type 2: Cardioprotection, and more! 35
From-omics to personalized medicine in nephrology: Integration is the key 35
DelCFHR3-1 influences graft survival in transplant patients with IgA nephropathy via complement-mediated cellular senescence 33
GLP-1 receptor agonists and renal outcomes in patients with diabetes mellitus type 2 and diabetic kidney disease: State of the art 33
Aldosterone: From Essential Tubular Regulator to Pathological Driver—Physiology, Disease, and Therapeutic Advances 32
Role of let-7b in the regulation of N-acetylgalactosaminyltransferase 2 in IgA nephropathy 32
Genome-wide association studies in kidney diseases: Quo Vadis 31
A New Vision of IgA Nephropathy: The Missing Link 22
Diabetes Mellitus in Kidney Transplant Recipients and New Hypoglycemic Agent Options 22
Future Designs of Clinical Trials in Nephrology: Integrating Methodological Innovation and Computational Power 18
CRISPR and gene editing for kidney diseases: Where are we? 16
A renal biopsy–anchored multi-marker signature involving AOPEP SNP-driven splicing, miR-27b-3p and glycated albumin for stratifying renal damage in type 2 diabetes 16
Future Designs of Clinical Trials in Nephrology: Integrating Methodological Innovation and Computational Power 12
Efficacy and Safety of Low-Dose ATG Plus Basiliximab Induction in Deceased Donor Kidney Transplantation 11
Totale 2.531
Categoria #
all - tutte 8.924
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.924


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 1 0 0 0 0 0 0
2021/20228 2 0 0 0 0 0 0 0 1 0 3 2
2022/202316 2 0 2 0 3 2 0 3 4 0 0 0
2023/202430 0 9 1 4 0 0 2 2 0 3 4 5
2024/2025529 2 0 4 6 4 5 39 14 27 27 198 203
2025/20261.944 358 183 396 694 286 27 0 0 0 0 0 0
Totale 2.531